Skip to content

Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

Research output: Contribution to journalArticle

  • Gabor G Kovacs
  • Isidro Ferrer
  • Lea T Grinberg
  • Irina Alafuzoff
  • Johannes Attems
  • Herbert Budka
  • Nigel J Cairns
  • John F Crary
  • Charles Duyckaerts
  • Bernardino Ghetti
  • Glenda M Halliday
  • James W Ironside
  • Seth Love
  • Ian R Mackenzie
  • David G Munoz
  • Melissa E Murray
  • Peter T Nelson
  • Hitoshi Takahashi
  • John Q Trojanowski
  • Olaf Ansorge
  • Thomas Arzberger
  • Atik Baborie
  • Thomas G Beach
  • Kevin F Bieniek
  • Eileen H Bigio
  • Istvan Bodi
  • Brittany N Dugger
  • Mel Feany
  • Ellen Gelpi
  • Stephen M Gentleman
  • Giorgio Giaccone
  • Kimmo J Hatanpaa
  • Richard Heale
  • Patrick R Hof
  • Monika Hofer
  • Tibor Hortobágyi
  • Kurt Jellinger
  • Gregory A Jicha
  • Paul Ince
  • Julia Kofler
  • Enikö Kövari
  • Jillian J Kril
  • Radoslav Matej
  • Ann C McKee
  • Catriona McLean
  • Ivan Milenkovic
  • Thomas J Montine
  • Shigeo Murayama
  • Jasmin Rahimi
  • Roberta D Rodriguez
  • Annemieke Rozemüller
  • Julie A Schneider
  • Christian Schultz
  • William Seeley
  • Danielle Seilhean
  • Fabrizio Tagliavini
  • Masaki Takao
  • Dietmar Rudolf Thal
  • Jon B Toledo
  • Markus Tolnay
  • Juan C Troncoso
  • Harry V Vinters
  • Serge Weis
  • Stephen B Wharton
  • Charles L White
  • Thomas Wisniewski
  • John M Woulfe
  • Masahito Yamada
  • Dennis W Dickson
Original languageEnglish
Pages (from-to)87-102
Number of pages16
JournalActa Neuropathologica
Issue number1
Early online date10 Dec 2015
DateAccepted/In press - 14 Nov 2015
DateE-pub ahead of print - 10 Dec 2015
DatePublished (current) - Jan 2016


Pathological accumulation of abnormally phosphorylated tau protein in astrocytes is a frequent, but poorly characterized feature of the aging brain. Its etiology is uncertain, but its presence is sufficiently ubiquitous to merit further characterization and classification, which may stimulate clinicopathological studies and research into its pathobiology. This paper aims to harmonize evaluation and nomenclature of aging-related tau astrogliopathy (ARTAG), a term that refers to a morphological spectrum of astroglial pathology detected by tau immunohistochemistry, especially with phosphorylation-dependent and 4R isoform-specific antibodies. ARTAG occurs mainly, but not exclusively, in individuals over 60 years of age. Tau-immunoreactive astrocytes in ARTAG include thorn-shaped astrocytes at the glia limitans and in white matter, as well as solitary or clustered astrocytes with perinuclear cytoplasmic tau immunoreactivity that extends into the astroglial processes as fine fibrillar or granular immunopositivity, typically in gray matter. Various forms of ARTAG may coexist in the same brain and might reflect different pathogenic processes. Based on morphology and anatomical distribution, ARTAG can be distinguished from primary tauopathies, but may be concurrent with primary tauopathies or other disorders. We recommend four steps for evaluation of ARTAG: (1) identification of five types based on the location of either morphologies of tau astrogliopathy: subpial, subependymal, perivascular, white matter, gray matter; (2) documentation of the regional involvement: medial temporal lobe, lobar (frontal, parietal, occipital, lateral temporal), subcortical, brainstem; (3) documentation of the severity of tau astrogliopathy; and (4) description of subregional involvement. Some types of ARTAG may underlie neurological symptoms; however, the clinical significance of ARTAG is currently uncertain and awaits further studies. The goal of this proposal is to raise awareness of astroglial tau pathology in the aged brain, facilitating communication among neuropathologists and researchers, and informing interpretation of clinical biomarkers and imaging studies that focus on tau-related indicators.

    Research areas

  • Aging, ARTAG, Tau astrogliopathy, Tau

Download statistics

No data available



  • ARTAG-ANP_R1_Final accepted (2)

    Rights statement: The final publication is available at Springer via

    Accepted author manuscript, 5 MB, PDF-document


View research connections

Related faculties, schools or groups